News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InflaRx Closes Funding to Move Its Complement Antibody Program into Clinical Trials for Sepsis Treatment


3/18/2009 10:37:10 AM

JENA, Germany--(BUSINESS WIRE)--InflaRx announced today the closing of its funding, led by Affentranger Associates alongside bm-t (beteiligungsmanagement thüringen gmbh).

Read at BioSpace.com

comments powered by Disqus
InflaRx
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES